Establishment and evaluation of individualized lung protection strategies for preterm / extremely preterm infants at birth

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000029856

Enrollment

Unknown

Registered

2020-02-15

Start date

2020-05-01

Completion date

Unknown

Last updated

2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchopulmonary dysplasia

Interventions

experimental group:Individualized lung protection strategy

control group:CPAP support

Eligibility

Sex/Gender

All

Age

0.1 Years to 0.1 Years

Inclusion criteria

Inclusion criteria: Extremely/ very premature infants (gestational age < 32 weeks) delivered in our hospital.

Exclusion criteria

Exclusion criteria: 1. The parents refused to sign the informed consent form; 2. Fetal factors: severe malformations that affect the effect of neonatal resuscitation, the HR at birth < 60 times / min, or other people who need immediate tracheal intubation and further resuscitation; 3. All other conditions that may affect the safety of newborns can be excluded in this study at the discretion of the on-site pediatrician.

Design outcomes

Primary

Measure	Time frame
intubation rate;CPAP pressure;FiO2;ventilator utilization rate;the incidence of pneumothorax;intestinal perforation;BPD;	—

Secondary

Measure	Time frame
chest compression rate;Apgar score;blood gas analysis;periventricular intraventricular hemorrhage (III-IV);necrotizing enterocolitis (more than bell stage II);retinopathy of prematurity;	—

Countries

China

Contacts

Public ContactWu Yan

Chongqing maternal and Child Health Hospital

19498874@qq.com+86 13996263690

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026